Topic: Coronary heart disease - Primary Care
Tuesday, 02 April 2019
A local GP practice in Milton Keynes has designed a valuable tool to triage patients presenting with chest pain and to help them avoid unnecessary emergency hospital admissions. The locality has no dedicated unit, so patients require either emergency hospital admission, a referral to Rapid Access Chest Pain Clinic (RACP), cardiology outpatient clinic (OPD), or management in primary care.
Wednesday, 06 December 2017
Percutaneous coronary intervention (PCI) is not significantly better than a placebo procedure in improving exercise capacity or symptoms even in patients with severe coronary stenosis, according to new UK research. The ORBITA study is the first double blind randomised controlled trial to directly compare stenting with placebo in patients with stable angina who are receiving high quality drug treatment.
Friday, 30 June 2017
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event and take advantage of our Early Bird discount.
Wednesday, 04 July 2018
Loneliness injures the heart and is a strong predictor of premature death, according to a study presented at EuroHeartCare 2018, the European Society of Cardiology's annual nursing congress. The study found that feeling lonely was a stronger predictor of poor outcomes than living alone, in both men and women.
Monday, 08 April 2019
Our regular Evidence in Practice feature summarizes recent scientific papers focusing on different aspects of cardiovascular medicine. This month we feature recent research showing that anti-inflammatory biological drugs used to treat severe psoriasis have the potential to prevent heart in patients with the condition. Over one year of treatment, biological therapy improved coronary artery plaques in a manner similar to a low-dose statin.
Wednesday, 04 April 2018
Addition of rivaroxaban to aspirin lowers major vascular events but increases major bleeding in patients with stable coronary artery disease. There was no signiﬁcant increase in intracranial bleeding or other critical organ bleeding. There was also a signiﬁcant net beneﬁt in favour of rivaroxaban plus aspirin and deaths were reduced by 23%.
Friday, 19 May 2017
The NICE Quality Standard (QS) on the diagnosis and management of stable angina has been updated to reflect changes to the NICE guideline on chest pain of recent onset. Statement 1 of the QS was changed to encourage people with features of typical or atypical angina to be offered 64-slice CT coronary angiography to confirm any diagnosis.
Category: Have You Heard